# Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy

> **NCT03453541** · PHASE4 · TERMINATED · sponsor: **Albany Medical College** · enrollment: 214 (actual)

## Conditions studied

- Analgesic Adverse Reaction

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **DRUG:** 0.9% Normal Saline

## Key facts

- **NCT ID:** NCT03453541
- **Lead sponsor:** Albany Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-21
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 214 (ACTUAL)
- **Why stopped:** Limited recruitment resources.
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03453541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03453541, "Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03453541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*